tiprankstipranks
Advertisement
Advertisement

PCROHLC Stock Latest News

Ro Expands GLP-1 Offering With Addition of Eli Lilly’s Foundayo Pill
Private CompaniesRo Expands GLP-1 Offering With Addition of Eli Lilly’s Foundayo Pill
13h ago
ROHLC
Ro Expands GLP-1 Portfolio With Addition of Eli Lilly’s Foundayo Pill
PremiumPrivate Companies
Ro Expands GLP-1 Portfolio With Addition of Eli Lilly’s Foundayo Pill
19h ago
ROHLC
Ro Adds Lilly’s Oral GLP-1 Foundayo to Expand Obesity Treatment Platform
PremiumPrivate Companies
Ro Adds Lilly’s Oral GLP-1 Foundayo to Expand Obesity Treatment Platform
19h ago
ROHLC
Ro Expands GLP-1 Weight-Loss Offering With Nationwide Launch of Zepbound KwikPen
PremiumPrivate Companies
Ro Expands GLP-1 Weight-Loss Offering With Nationwide Launch of Zepbound KwikPen
8d ago
ROHLC
Ro Targets GLP-1 Market With Wegovy Pricing and Membership Savings
PremiumPrivate Companies
Ro Targets GLP-1 Market With Wegovy Pricing and Membership Savings
9d ago
ROHLC
Ro Expands Wegovy Pricing Discounts and Ties Savings to Upcoming Membership Program
PremiumPrivate CompaniesRo Expands Wegovy Pricing Discounts and Ties Savings to Upcoming Membership Program
10d ago
ROHLC
Ro Deepens Novo Nordisk Partnership With Lower-Cost Wegovy Plans and Expanded GLP-1 Offering
Premium
Private Companies
Ro Deepens Novo Nordisk Partnership With Lower-Cost Wegovy Plans and Expanded GLP-1 Offering
10d ago
ROHLC
Ro Expands GLP-1 Access With Wegovy Pricing and Membership Savings Focus
Premium
Private Companies
Ro Expands GLP-1 Access With Wegovy Pricing and Membership Savings Focus
10d ago
ROHLC
Ro Highlights GLP-1 Patient Outcomes and Lifestyle Impact in Obesity Care
PremiumPrivate Companies
Ro Highlights GLP-1 Patient Outcomes and Lifestyle Impact in Obesity Care
2M ago
ROHLC
Ro Highlights GLP-1 Patient Outcomes and Lifestyle Impact
PremiumPrivate Companies
Ro Highlights GLP-1 Patient Outcomes and Lifestyle Impact
2M ago
ROHLC
Ro Emphasizes Lifestyle Outcomes in GLP-1 Obesity Care Campaign
PremiumPrivate Companies
Ro Emphasizes Lifestyle Outcomes in GLP-1 Obesity Care Campaign
2M ago
ROHLC
Ro Launches First Super Bowl Campaign to Scale GLP-1 Weight-Loss Business
PremiumPrivate Companies
Ro Launches First Super Bowl Campaign to Scale GLP-1 Weight-Loss Business
2M ago
ROHLC
Ro Partners with Amgen to Use Real-World Data to Tackle GLP-1 Access Barriers in Obesity Care
PremiumPrivate CompaniesRo Partners with Amgen to Use Real-World Data to Tackle GLP-1 Access Barriers in Obesity Care
3M ago
ROHLC
Ro Becomes Key Direct-to-Patient Channel for Novo Nordisk’s New Oral Wegovy Launch
Premium
Private Companies
Ro Becomes Key Direct-to-Patient Channel for Novo Nordisk’s New Oral Wegovy Launch
3M ago
ROHLC
Ro’s Telehealth Platform Achieves Significant Weight Loss in Semaglutide Study
Premium
Private Companies
Ro’s Telehealth Platform Achieves Significant Weight Loss in Semaglutide Study
4M ago
ROHLC
Ro Showcases Innovative Obesity Care Research at ObesityWeek 2025
PremiumPrivate Companies
Ro Showcases Innovative Obesity Care Research at ObesityWeek 2025
5M ago
ROHLC
Ro Introduces New Scale to Measure ‘Food Noise’ in Obesity Research
PremiumPrivate Companies
Ro Introduces New Scale to Measure ‘Food Noise’ in Obesity Research
5M ago
ROHLC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >